• 7394 malaria professionals are enjoying the free benefits of MalariaWorld today

Tanzani

Open Access | Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children

Author(s): 
John Lusingu, Ally Olotu, Lorenz von Seidlein, et al.
Reference: 
PLoS ONE 5(11): e14090
Contact email: 
lseidlein@gmail.com

The malaria vaccine candidate, RTS,S/AS01E, showed promising protective efficacy in a trial of Kenyan and Tanzanian children aged 5 to 17 months. Here we report on the vaccine's safety and tolerability.

Syndicate content